Alternative Medications for MDD, Anxiety, and PTSD

First-Line SSRI Alternatives

The American College of Physicians recommends sertraline as a first-line alternative to paroxetine, demonstrating equivalent efficacy across MDD, anxiety disorders, and PTSD, with FDA approval for PTSD 1, 2
Sertraline shows robust evidence in multiple double-blind, placebo-controlled trials for PTSD, with quality of life improvements similar to paroxetine for depression with anxiety symptoms 2
Fluoxetine is equally effective as paroxetine for MDD and anxiety symptoms, with similar improvements in health-related quality of life, work functioning, and social functioning 1, 3

Venlafaxine may offer advantages in specific presentations, with limited evidence suggesting superior efficacy to fluoxetine for patients with prominent anxiety symptoms and melancholia 3
Duloxetine demonstrates equivalent efficacy to paroxetine for maintaining remission in MDD, and is particularly useful when comorbid pain is present, with similar response rates to paroxetine in patients with depression and pain 3

Mirtazapine has the fastest onset of action compared to all SSRIs, with statistically significant earlier response than paroxetine, though response rates equalize after 4 weeks 2, 3
Bupropion has equivalent efficacy to sertraline when switching from failed initial antidepressant therapy, but shows similar efficacy to sertraline for depression with anxiety, and is ineffective for PTSD 1, 3

Approximately 25% of patients achieve remission after switching to another SSRI or venlafaxine, with evidence supporting continuation rather than switching if partial response to SSRI 3, 2